These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26222044)

  • 1. Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity.
    Kolotkin RL; Chen S; Klassen P; Gilder K; Greenway FL
    Clin Obes; 2015 Oct; 5(5):237-44. PubMed ID: 26222044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between health-related quality of life and weight loss.
    Kolotkin RL; Crosby RD; Williams GR; Hartley GG; Nicol S
    Obes Res; 2001 Sep; 9(9):564-71. PubMed ID: 11557837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).
    Apovian CM; Aronne L; Rubino D; Still C; Wyatt H; Burns C; Kim D; Dunayevich E;
    Obesity (Silver Spring); 2013 May; 21(5):935-43. PubMed ID: 23408728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
    Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes.
    Apovian CM
    Future Cardiol; 2016 Mar; 12(2):129-38. PubMed ID: 26679384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in health-related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity.
    Kolotkin RL; Gabriel Smolarz B; Meincke HH; Fujioka K
    Clin Obes; 2018 Feb; 8(1):1-10. PubMed ID: 29045079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in randomized controlled trials of lorcaserin for obesity management: what mediates improvement?
    Kolotkin RL; Crosby RD; Wang Z
    Clin Obes; 2017 Dec; 7(6):347-353. PubMed ID: 28815987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo.
    Greenway FL; Dunayevich E; Tollefson G; Erickson J; Guttadauria M; Fujioka K; Cowley MA;
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4898-906. PubMed ID: 19846734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
    Kolotkin RL; Gadde KM; Peterson CA; Crosby RD
    Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version.
    Kolotkin RL; Williams VSL; Ervin CM; Williams N; Meincke HH; Qin S; von Huth Smith L; Fehnel SE
    Clin Obes; 2019 Jun; 9(3):e12310. PubMed ID: 30993900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrave--a combination of bupropion and naltrexone for weight loss.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):112-4. PubMed ID: 25372849
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a brief measure to assess quality of life in obesity.
    Kolotkin RL; Crosby RD; Kosloski KD; Williams GR
    Obes Res; 2001 Feb; 9(2):102-11. PubMed ID: 11316344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in health-related quality of life with liraglutide 3.0 mg compared with placebo in weight management.
    Kolotkin RL; Fujioka K; Wolden ML; Brett JH; Bjorner JB
    Clin Obes; 2016 Aug; 6(4):233-42. PubMed ID: 27198973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.
    Wadden TA; Foreyt JP; Foster GD; Hill JO; Klein S; O'Neil PM; Perri MG; Pi-Sunyer FX; Rock CL; Erickson JS; Maier HN; Kim DD; Dunayevich E
    Obesity (Silver Spring); 2011 Jan; 19(1):110-20. PubMed ID: 20559296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy.
    Fujioka K; Plodkowski R; O'Neil PM; Gilder K; Walsh B; Greenway FL
    Int J Obes (Lond); 2016 Sep; 40(9):1369-75. PubMed ID: 27328752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
    Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
    Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample.
    Kolotkin RL; Crosby RD
    Qual Life Res; 2002 Mar; 11(2):157-71. PubMed ID: 12018739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone/bupropion: an investigational combination for weight loss and maintenance.
    Makowski CT; Gwinn KM; Hurren KM
    Obes Facts; 2011; 4(6):489-94. PubMed ID: 22249001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone-bupropion combination?
    Citrome L
    Int J Clin Pract; 2010 Oct; 64(11):1462-1465. PubMed ID: 20846190
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity.
    Smith SR; Fujioka K; Gupta AK; Billes SK; Burns C; Kim D; Dunayevich E; Greenway FL
    Diabetes Obes Metab; 2013 Sep; 15(9):863-6. PubMed ID: 23489381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.